The Global Sprycel Market is estimated to be valued at US$ 5.68 billion in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The Sprycel Market offers a business description and use cases of products associated with the treatment of leukemia. Sprycel, developed by Bristol-Myers Squibb (BMS), is a targeted ... Read more
